2026-2027 COVID-19 Vaccine Available for Order 

sara

To: Maine Immunization Program Providers 

From: Maine Immunization Program 

Subject: 2026-2027 COVID-19 Vaccine Available for Order 

Date: September 29, 2026 

 

2026-2027 COVID-19 Vaccine Available for Order 

The Maine Immunization Program (MIP) is pleased to announce that we currently have a limited quantity of Moderna (Spikevax) COVID-19 vaccine available to order for children ages 6 months – 18 years for the 2026-2027 respiratory virus season.  

Due to initial limited quantities, ordering is currently limited to two Moderna (Spikevax) pediatric products.  MIP will update providers as additional presentations become available to order for pediatrics, and when ordering opens for uninsured and underinsured adults ages 19-64.  

2026-2027 COVID-19 Vaccine Presentations: Current Availability for Children 6 Months Through 18 Years Old 

Manufacturer Product NDC# MIP-Eligible Population Presentation Maximum Ordering Quantity

Moderna - Spikevax 

80777-0115-80 

Children age 6 months – 11 years

0.25 mL single dose pre-filled syringe with red label; 10-pack

100 doses  

Moderna - Spikevax 

80777-0114-96 

Children age 12 – 18 years

0.5 mL single dose pre-filled syringe with blue label; 10-pack 

100 doses 

Recommendations for Children 6 Months Through 18 Years: 

The American Academy of Pediatrics (AAP) recommends COVID-19 vaccination for children ages 6 months–18 years, including:  

  • All infants and children 6 through 23 months of age 
  • Children 6 months through 18 years of age who are moderately or severely immunocompromised 
  • Children 2 through 18 years of age in certain additional risk groups, including those at high risk of severe COVID-19 
  • Residents of long-term care facilities or other congregate settings 
  • Children who have never been vaccinated against COVID-19 
  • Children whose household contacts are at high risk for severe COVID-19. 

 For more information: